Canfield’s cutting edge VISIA Skin Analysis has been chosen by aestheticians, dermatologists, and other healthcare professionals as their Favorite Diagnostic Tool in the 2023 Aestheticians’ Choice Awards. Achieving this award for the fifth time, VISIA has become the gold standard for skin consultations worldwide.
Announcements News
VECTRA® H2 - the most advanced solution for Face, Breast, and Body – is now wireless. Using Wi-Fi, the uploading process will now transfer captures seamlessly directly into the VECTRA® software patient chart. This system will no longer require a cable to upload patient captures onto your computer.
Canfield Scientific, the global leader providing skin imaging systems and services for pharmaceutical, biotech, and medical device companies, is pleased to announce it has achieved ISO/IEC 27001:2013 (ISO 27001) certification. Having ISO 27001 certification signifies Canfield’s commitment to the security, confidentiality, integrity, and availability of sensitive health-related patient and customer information.
Following last year’s successful launch of the world-class medical dermatology education program Dreamoscopy™, Alfredo Medici and the Canfield s.r.l. team will be conducting Dreamoscopy 2: Imaging in the Modern Dermatology Clinic. The event will be taking place on December 3rd, 2022, at their state-of-the-art facility in Spilamberto (Modena), Italy.
Canfield’s VECTRA WB360 whole-body imaging system was recently donated to the “Andreas Syggros” Hospital by the Onassis Foundation, marking the first WB360 system to be featured in a Greek hospital. This system, which can offer 3D imaging through 46 stereo-vision pods that take pictures with cross-polarized and non-polarized lighting, generating a single 3D image of the entire body, is considered the future of Dermatology and Skin Oncology. As an addition to the newly reconstructed Melanoma and Skin Cancer Center, the 3D imaging system will provide clinicians and researchers the ability to identify changes in suspicious lesions on the surface of the skin over time. The WB360 creates a precise 3D body map of the patient, which gives “Andreas Syggros” Hospital a way to combat the country’s high rate of melanoma. As of today, VECTRA WB360, a synonym for medical innovation and research in the field of dermatology, will safeguard the extraordinary work undertaken in this updated Center.
Canfield’s VECTRA WB360 was recently installed at the Hopital de la Conception-AP-HM Marseille, making it the first WB360 system to be featured in a French hospital. The whole-body imaging system will be the centerpiece of the hospital’s multi-room system for clinical dermatology, where it includes rooms for body mapping and confocal microscopy. The VECTRA WB360 captures patient images using 46 stereo vision pods with cross-polarized and non-polarized lighting, generating a single 3D image of the entire body. Incorporating Canfield’s AI-driven DermaGraphix® software, the 3D images are used for pigmented lesion and rash surveillance. Using VECTRA’S 3D imaging technology Prof. Jean-Jacques Grob and Jilliana Monnier, MD can examine individual lesions, record data, and monitor patients over time. This latest installation in Marseille is one of fifteen WB360 systems in Europe and is the fifth system so far in 2022.
Canfield is proud to announce the VISIA® Skin Analysis System has been voted Favorite Diagnostic Tool in the 2022 Aestheticians' Choice Awards. This is the fourth time VISIA has achieved this award.
Building on its successful expansion into the European dermatology and aesthetics imaging market, Canfield Scientific is announcing the launch of Canfield Scientific s.r.l., created with the acquisition of Medici Medical s.r.l. Medici Medical is responsible for numerous innovations in dermoscopy and has produced best-in-class technology for years, making them the preferred choice of dermatologists in Italy. To celebrate the launch, Alfredo Medici and his team are conducting a special scientific and educational program called Dreamoscopy™, to provide the most advanced learning opportunities in medical imaging, at their brand-new, state of the art facility in Spilamberto (Modena), Italy.
Canfield’s VECTRA WB360 whole-body imaging system was recently installed at the clinic of Dr. Gerd Kautz and Dr. Ingrid Kautz in Konz, Germany, becoming the first system installed in a German private practice. The 3D imaging system will assist Dr. Gerd Kautz, his wife Dr. Ingrid Kautz, and other staff members as they examine patients for the earliest signs of melanoma using the system’s advanced body mapping technology. The VECTRA WB360 captures patient images using 92 SLR-cameras flashing with polarized and cross-polarized lighting for an enhanced look at skin features. After the images are captured, clinicians can view the entire skin’s surface using Canfield’s AI-driven DermaGraphix software, as they screen for signs of melanoma and monitor changes over time. Starting in early October, staff members at the practice will use the system to examine individual lesions and monitor their patients for potential skin cancer. Their practice is now the fifth VECTRA WB360 installation in Germany, including installations at the University Hospital in Erlangen, University Hospital in Munich, University Hospital in Dresden, and the Technical University of Munich.
Jack Arbiser, MD, PhD, principal investigator and professor of dermatology at Emory University School of Medicine, has identified a new compound as an effective treatment for rosacea. Canfield’s VISIA Skin Analysis was used in clinical trials to document decreases in redness and track responses to the novel topical treatment, ACU-D1 (Accuitis Inc.).
